Taysha Gene Therapies Quick Ratio 2020-2024 | TSHA

Taysha Gene Therapies quick ratio from 2020 to 2024. Quick ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated by subtracting inventory from current assets and dividing by current liabilities.

Taysha Gene Therapies Quick Ratio 2020-2024 | TSHA

Taysha Gene Therapies quick ratio from 2020 to 2024. Quick ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated by subtracting inventory from current assets and dividing by current liabilities.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$19.4B
Dr Reddy's Laboratories (RDY)$12.6B
BridgeBio Pharma (BBIO)$5.1B
Bausch Health Cos (BHC)$3.4B
Amphastar Pharmaceuticals (AMPH)$2.4B
Supernus Pharmaceuticals (SUPN)$2B
Personalis (PSNL)$241M
Assembly Biosciences (ASMB)$106M
Sol-Gel Technologies (SLGL)$16M
Evoke Pharma (EVOK)$5M
Teligent (TLGT)$0M